Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan

MLA

Takayuki, Fujii, et al. “Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-Center, Retrospective Study in Japan.” Internal Medicine, vol. 61, June 2022, pp. 1681–86. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d082fd23efb9a9c077724c8116507816&authtype=sso&custid=ns315887.

APA

Takayuki, F., Masao, H., Keiko, M., Shiori, N., Shin, O., Tomoyuki, U., Morihiro, I., Moe, O., Atsuhiro, Y., Jurika, M., Calvin, D., Kiyoko, I.-H., Seiya, Y., & Yoshihiro, K. (2022). Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan. Internal Medicine, 61, 1681–1686.

Chicago

Takayuki, Fujii, Hagihara Masao, Mitamura Keiko, Nakashima Shiori, Ohara Shin, Uchida Tomoyuki, Inoue Morihiro, et al. 2022. “Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-Center, Retrospective Study in Japan.” Internal Medicine 61 (June): 1681–86. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d082fd23efb9a9c077724c8116507816&authtype=sso&custid=ns315887.